Showing results (111-120 of 941) with videos related to
Sort By:
Pageof 95
Diabetes & Vascular Disease Research|May 13, 2022
Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flowYulan Liu, Hong Xiang, Wenfang Xiong, et al.Diabetes & Vascular Disease Research|February 1, 2018
Long non-coding RNA nuclear paraspeckle assembly transcript 1 inhibits the apoptosis of retina Müller cells after diabetic retinopathy through regulating miR-497/brain-derived neurotrophic factor axisXiu-Juan LiDiabetes & Vascular Disease Research|December 13, 2018
Aerobic exercise training improves insulin-induced vasorelaxation in a vessel-specific manner in rats with insulin-treated experimental diabetesMatthew W McDonald, T Dylan Olver, Michelle S Dotzert, et al.Diabetes & Vascular Disease Research|March 16, 2018
Association of serum C1q tumour necrosis factor-related protein 9 with the severity of lower extremity peripheral arterial disease in type 2 diabetes patientsWengao Jiang, Qiang Tang, Lei Zhang, et al.Diabetes & Vascular Disease Research|March 10, 2020
Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery diseaseI-Te LeeDiabetes & Vascular Disease Research|January 8, 2014
Tick-tock: is your cardiometabolic risk on the clock?Robert Stöhr, Nikolaus Marx, Massimo FedericiDiabetes & Vascular Disease Research|January 28, 2014
Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathwayRong Guo, Baoxin Liu, Ke Wang, et al.Diabetes & Vascular Disease Research|April 23, 2021
Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitorsMei Qiu, Liang-Liang Ding, Miao Zhang, et al.Diabetes & Vascular Disease Research|March 29, 2023
High serum Bhlhe40 levels are associated with subclinical atherosclerosis in patients with type 2 diabetes mellitus: A cross-sectional studyHui Xu, Qun-Yan Xiang, Shuang Li, et al.Diabetes & Vascular Disease Research|October 30, 2008
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart diseaseHelene von Bibra, Michaela Diamant, Peter G Scheffer, et al.Pageof 95